Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lewis Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113195454A reveals a novel synthesis route for Formula VI intermediates, offering superior purity over 99% and safer Lewis acid demethylation for scalable API manufacturing.
Patent CN111072734A reveals a high-yield route to Doxifluridine using a styryl-benzoate ribose donor, offering mild conditions and 98% coupling efficiency for API manufacturing.
Patent CN117700410B reveals a high-yield synthesis for Paliperidone intermediates. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel patent CN105646137B offers cost-effective posaconazole intermediate synthesis without Grignard reagents, ensuring supply chain stability.
Patent CN102584905B details a novel Blanc chloromethylation method. This report analyzes cost reduction in pharma intermediates manufacturing and supply chain reliability for global buyers.
Patent CN114591278A details a novel ethylene carbonate cyclization method for prucalopride intermediates, offering high purity, safety, and cost reduction in API manufacturing.
Patent CN108046998A reveals high purity synthesis. Offers supply chain stability and cost efficiency for cosmetic active ingredient manufacturing.
Novel patent CN116836046B enables high-purity 4-Biphenylformaldehyde production. Achieve cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel AlCl3 catalyzed route for prucalopride intermediate. High yield, safe scale-up, cost-effective manufacturing for global supply chains.
Patent CN118724683A reveals advanced borneol synthesis. Achieve high purity and cost reduction in flavor & fragrance intermediates manufacturing with scalable methods.
Patent CN103159746B reveals a high-yield Tegafur synthesis method. This report analyzes cost reduction in API manufacturing and supply chain reliability for global buyers.
Patent CN109438168B details a novel BrCl bromination method for bromopentafluorobenzene, offering superior atom economy and cost reduction for fine chemical manufacturing.
Discover the green synthesis of Amiodarone Hydrochloride via Lewis acid catalysis. This patent offers cost reduction in API manufacturing and high-purity intermediates.
Patent CN101037375A details a cost-effective triarylmethane synthesis using iron catalysts, offering high purity and scalable manufacturing for global pharmaceutical supply chains.
Novel BF3-catalyzed etherification method for Bepotastine intermediate. Enhances yield, reduces waste, ensures supply chain stability for pharmaceutical manufacturing.
Novel BF3 and CsOH catalyzed route for prochloraz intermediate. High yield, mild conditions, scalable agrochemical manufacturing solution.
Patent CN101602681A details a solvent-free Ni(OAc)2 catalyzed route for beta-enaminones, offering high purity and eco-friendly processing for pharmaceutical intermediates.
Patent CN112079803A details high-purity 4-halophthalic anhydride synthesis. Offers supply chain reliability and cost advantages for global pharmaceutical and flame retardant manufacturers.
Patent CN116102610B reveals one-pot steroid synthesis reducing waste. Offers cost reduction in pharmaceutical intermediates manufacturing with high purity.
Patent CN116003369A reveals a novel Sc(OTf)3-catalyzed hydrogen migration strategy for efficient spirochroman synthesis, offering significant cost and supply chain advantages for pharmaceutical intermediate manufacturing.